FDA 522 Protocol Amendment Impact Calculator
Protocol changes in a Section 522 program can be necessary, but they are rarely free. This calculator estimates added schedule and spend from retraining, re-consent, site updates, and data rework so teams can decide early whether an amendment is proportionate.
Interactive Calculator
Run calculation to view projected delay, incremental cost, and amendment severity tier.
Why Amendment Modeling Is Critical
When 522 teams discuss amendments, they often focus on scientific quality and underweight execution cost. In practice, amendment risk is operational: retraining calendars, local process variation, query backlog, and re-consent logistics. If these impacts are not modeled before approval, timeline confidence degrades and budget reserves are consumed quickly.
A good amendment decision balances evidence value against execution drag. Some changes improve eventual report quality enough to justify disruption. Others create complexity without proportionate benefit. This calculator helps make that tradeoff explicit by showing expected impact in both time and money.
The output should feed governance, not replace it. Use the score as an escalation signal and pair it with protocol rationale, patient-safety implications, and FDA communication strategy.
Interpreting the Amendment Tier
Low impact amendments are usually manageable inside standard cadence if governance and communication are tight.
Moderate impact amendments usually need explicit mitigation plans, milestone resets, and commercial alignment with providers.
High impact amendments should trigger executive review with scenario options: proceed, phase the change, or defer.
Mitigation Playbook Before Approving an Amendment
- Draft a site-by-site activation and retraining plan with deadlines and owners.
- Define re-consent workflow and evidence retention standards up front.
- Set temporary data-cleaning surge capacity if query burden is expected to rise.
- Re-baseline interim/final reporting milestones with explicit assumptions.
- Confirm change-order mechanics in provider contracts before implementation.
Teams that pre-negotiate this playbook avoid the most common failure mode: approving technically valid amendments that create uncontrolled operational drag.
References
- [1] FDA, Postmarket Surveillance Under Section 522: official overview
- [2] eCFR, 21 CFR Part 822: regulatory text
- [3] FDA, Design and conduct resources for device studies: clinical studies resources